BioFusion, University of Sheffield, Agios Pharmaceuticals, Oligomerix, Alzheimer’s Drug Discovery Foundation, Saint Louis University, Vivendy Therapeutics, International Stem Cell Corporation, Michigan State University, Olink, Uppsala University, Biométho | GenomeWeb
UK’s BioFusion Expands Sheffield Pact, Raises $4.2M, Changes Name
 
BioFusion, a UK-based company specializing in the commercialization of university technologies, said this week that it has expanded an existing 10-year exclusive agreement with the University of Sheffield to include IP in areas other than life sciences.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.